rheumatoid arthritis
| 4 min read
Elizabeth Laws leads Sanofi’s inflammation and immunology development pipeline to test the first oral TNFR1 inhibitor for rheumatoid arthritis and psoriasis.
| 10+ min read
Once symptoms show up, it’s too late to cure many autoimmune diseases. Researchers are investigating ways to prevent the conditions from starting at all.
| 3 min read
In rheumatoid arthritis, damaged joints contain fibroblasts that prompt nerve cell growth, potentially causing pain even in the absence of inflammation.
| 6 min read
Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs.
Available on Demand
Re-engineering immune cells helps reverse immune dysregulation associated with autoimmune diseases.
| 3 min read
The European Commission has approved AbbVie’s RINVOQ (upadacitinib) for treatment of psoriatic arthritis and ankylosing spondylitis
Page 1 of 1 - 6 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe